CN102245770A - Method for purification of nucleic acids, particularly from fixed tissue - Google Patents
Method for purification of nucleic acids, particularly from fixed tissue Download PDFInfo
- Publication number
- CN102245770A CN102245770A CN2009801497428A CN200980149742A CN102245770A CN 102245770 A CN102245770 A CN 102245770A CN 2009801497428 A CN2009801497428 A CN 2009801497428A CN 200980149742 A CN200980149742 A CN 200980149742A CN 102245770 A CN102245770 A CN 102245770A
- Authority
- CN
- China
- Prior art keywords
- sample
- sample receiver
- magnetic
- clamper
- particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T137/00—Fluid handling
- Y10T137/8376—Combined
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to a method for purification of nucleic acids, to a kit for performing the method according to the invention and to a new application of magnetic particles for purification of a biological sample. The method according to the invention comprises the following steps: a) accommodating of the sample in a first sample vessel in an aqueous solution and lysing of the sample under non-chaotropic conditions; suspending of first magnetic particles in the solution and inserting of the first sample vessel in a sample vessel holder, wherein the sample vessel is inserted in the annular interior space of a ring magnet associated with the sample vessel holder; separating of the solution from the magnetic particles; and isolating of the nucleic acids from the solution.
Description
The present invention relates to the method for purification of nucleic acid, the system that implements the inventive method and the sample receiver clamper that is used for the purifying biological sample.
Recently, the importance of molecular diagnostics increases day by day.Molecular diagnostics has begun to be applied to clinical diagnosis disease (comprising detecting pathogen infection, detect genovariation, find the risks and assumptions of circulating tumor cell and identifying disease inherited genetic factors etc.).But the method for molecular diagnostics also is applied in veterinary medicine, environmental analysis and the nutritive substance test simultaneously.The Another Application field is for looking into research in the scope in the research of pathology/cytology research institute or in legal medical expert's inquiry.Also use gene diagnosis, legislator to plan in healthcare field (for example studying the pathogen infection-degree of freedom (Infektionserreger-Freiheit) of banked blood) simultaneously in these tests of usefulness Legal Norm in the future.The method of using in clinical molecular diagnosis is (as hybridization or amplification technique such as PCR (polymerase chain reaction), TMA (amplification of transcriptive intermediate), LCR (ligase chain reaction), bDNA (branched DNA) or NASBA (based on the amplification of nucleotide sequence)-technology) in basic scientific research work, also belong to ordinary method.
Especially, foranalysis of nucleic acids has been opened the new possibility of the prospect that is full of by determining the genetic expression in the tissue in the research of tumor disease and diagnosis.Therefore, for example, so-called microarray system has been opened in single reaction unit and have been determined up to a hundred or even the possibility of thousands of genetic expressions.The nucleic acid (as RNA or cDNA) of sample material, purifying is applied to chip, and this chip comprises corresponding seizure oligonucleotide, thereby the nucleic acid in this sample can be detected by hybridization.In addition, other detect the method for nucleic acid in sample, and for example amplification method such as polymerase chain reaction (PCR) also generally uses.
Basic problem in the foranalysis of nucleic acids is a specimen preparation.Sample to be studied generally includes the cell or tissue that contains interference, the insoluble composition of part (so-called fragment (Debris)), and these become the separation and the analysis of branch's interfere with subsequent.When these insoluble compositions appear at from ight soil/movement, blood, wart, calcified tissue's (bone) or other serious necrotic tissues isolating nucleic acid especially.Yet fragment also comprises soluble components on its broad sense, the oxyphorase that discharges from red corpuscle for example, and its serious excessive existence, and can during isolating nucleic acid, remove.
Particularly the aggravation of these problems is serious in tumor diagnostics because usually use this moment formaldehyde fixed, (formalin-fixed paraffin-embedded is FFPE-Schnitte) as sample material in paraffin-embedded section.When as during the examination of living tissue when the patient materialses, when perhaps in surgical operation, getting the sample of tumour material, organization material formaldehyde fixed, and being embedded in the paraffin, thereby can preserve this sample material.In the nurturing period, same after in tissue block (Gewebeblock) for many years, fixedly connect seriously crosslinked (nucleic acid and protein, protein each other, or nucleic acid is each other) that (Fixantien) causes biomolecules.The inside and outside cell of these crosslinking structures helps to generate insoluble fragment, or cleavable or be difficult to the cracked fragment not.Usually assess for the pathologist from these specimen preparation sections that are embedded in the paraffin; Yet these sections equally can be as the parent material in the foranalysis of nucleic acids.In this case, cell debris and paraffin must be removed during the nucleic acid purification after the cracking.
In addition, relating to problem interfering, part insoluble composition (fragment) also can take place during purifying is from ight soil sample (movement, ight soil (Kot)).The ight soil sample not only comprises the indigestibility composition (coarse food grain) of food, also comprises indigested residuum, and as fat, starch, connective fiber and meat fiber and water, they are not absorbed on the top of large intestine.The endogenous substance that exists comprises: the intestinal cells that comes off, the residuum of digestive ferment and mucus.In addition, a spot of bile itself and also can discharge with a spot of Yelkin TTS and a spot of other phosphatide of protection intestinal mucosa and can discharge together by follower ight soil from gall-bladder.
In order to reduce cost and to keep the time from specimen preparation to the determination and analysis result short as far as possible, important purpose is to make the method for purification of nucleic acid effective as far as possible, and implements this method by the automatization means as far as possible.This is specially adapted to diagnostics.Highly be suitable for automated method and be method that those can carry out and that can carry out with normalized form (for example, 96 well plate format) in the least possible differential responses container, move the liquid automatic gear efficiently because can use in the method.Therefore, there is demand in the prior art to simple, efficient and supermatic preparation method of sample.
Common nucleic acid purification method is included in cracking sample under the chaotropic condition, extracts purifying, sedimentation and from liquid phase for example phenol-chloroform extracted solution purifying (referring to people such as Sambrook, Molecular cloning-a laboratory manual, the third edition, Cold Spring Harbor Laboratory, Cold Spring Harbor Press, 2001, ISBN-13:978-0879695774), or based on the purification process of post, as in WO 2003040364-A1, putting down in writing.
The method of common isolating nucleic acid has been disclosed among the Chomczynski (US 5,346,994), and comprise based on use phenol and chaotropic compound guanidinium isothiocyanate from liquid phase separation the method from the organization material purification of nucleic acid.This sample must carry out centrifugal after adding guanidinium isothiocyanate (GTC) and phenol/chloroform by homogenization in the aqueous solution.Protein is present in the organic phase, and DNA is present in alternate, and RNA is present in aqueous phase.RNA can be precipitated out from aqueous phase.Yet this method can not be reliably from FFPE tissue sample purifying RNA.
Other known DNA or RNA separation method use chaotropic salt or phenol extraction liquid usually.
EP0819696 discloses a kind of method of purification of nucleic acid, and it is based on nucleic acid being bonded to silicon oxide (Silika) or other silica derivatives under chaotropic condition.Cracking takes place in this sample in chaotropic lysis buffer, and nucleic acid is bonded to silica matrix (Silikamatrix).
Method by paraffin section (Paraffinschnitten) purification of nucleic acid well known in the prior art at first needs loaded down with trivial details deparaffinization, wherein, paraffin is removed by dimethylbenzene usually, and follows and loaded down with trivial details carry out rehydration effect (Rehydratisierung) with dimethylbenzene/alcohol dilution sequence.
For example, WO 200146402A1 has put down in writing a kind of method from fixed paraffin section purifying RNA, wherein at first paraffin section is placed the Eppendorf reaction vessel, and uses dimethylbenzene deparaffnize.Then section must be carried out the rehydration effect with dimethylbenzene/alcohol dilution series (Verd ü nnungsreihe).Then, sample long-time (5 to 120 minutes) in chaotropic solution is heated with purifying RNA.Although this method has realized effective deparaffinization, it is loaded down with trivial details, and owing to need repeatedly centrifugation step, is not to be applicable to very much automatization.
In addition, EP1510577 has also disclosed a kind of method, and wherein nucleic acid is bonded to magnetic-particle under chaotropic condition, and can separate from the sample supernatant liquor by applying magnetic field.WO 1990014891A1 has disclosed a kind of magnetic specimen holder, and it can be used for this purpose.Yet, in the method, do not exist under the non-chaotropic condition cell debris or deparaffinization in the purifying sample in advance.But when purification of nucleic acid, the existence of fragment in sample has disadvantageous effect, is disadvantageous especially in automatic mode, because fragment can stop up transfer pipet point, suction tube etc., and can damage and is used to monitor the pressure transmitter that moves the liquid step.
Therefore, consider prior art, have needs, particularly to being suitable for the needs of automated method to improved purification of nucleic acid method.
Definition
Term " biological material " is meant any sample that comprises cell or cell material, cell particularly, freeze drying cell, fixed cell, movement/ight soil, dark yellow tectum (buffy coat, the white corpuscle part of blood), ascites, cotton swab (Abstriche), particularly cheek cotton swab or throat cotton swab still are more preferably neck cotton swab, phlegm, organ spot (Organpunktate), sperm, tissue sample, fixing organization sample, fixing or the tissue slice of fixing organization sample not, the paraffin section of freeze-drying section and paraffin section, particularly formaldehyde fixed particularly, the tumour material, biopsy sample, blood sample, particularly whole blood or blood part, cell suspension, and just all comprise the sample of cellular constituent the most in the broadest sense, wherein so-called cellular constituent should refer to intact cell and cellular constituent.
In addition, term " biological material " comprises that also other contain the biomaterial of nucleic acid, and for example serum or blood plasma particularly contain viral serum or blood plasma, the serum sample that preferred especially HIV-and HCV-infect, secretory product, CSF (Liquor), bile, lymph liquid, urine.Similarly, its can for be derived from biological chemistry or biotechnological means and will be through subsequent purification contain the biological nucleic acid material.
Term " cell () " be meant prokaryotic cell prokaryocyte and eukaryotic cell.
Term " cracking sample " comprises that the cell or the cellularstructure that make in the sample break.It is particularly including mechanical lysis method (as ultrasonic), thermo-cracking (as freeze-thaw cycle, heating sample) and chemical cracking (as using washing composition (Detergentien)).Yet term " cracking sample " is not limited to cell, and can represent to discharge nucleic acid by the method for using record from non cellular organism structure or mixture.
Term " nucleic acid " comprise chain length greater than the oligomerization of 10 monomeric units or polybribonucleotide or 2 '-deoxyribonucleotide.Monomeric unit in the nucleic acid 3 of adjacency monomeric unit ' and 5 ' hydroxyl between connect via phosphodiester bond, and heterocyclic bases (heterocyclische Base) is connected to 1 ' atom of each carbohydrate content with glycosidic link.Nucleic acid can form double-stranded and three chains by forming intermolecular hydrogen bonding.This also represents to comprise protein/nucleic acid complexes, and nucleic acid and synthesizing ribonucleotide, as morpholine class (Morpholinos), LNAs or PNAs.
Term " chaotropic condition " is meant the solvent condition in the presence of chaotropic reagent or compound.Chaotropic reagent or compound for a change or the compound of secondary structure, tertiary structure and the quaternary structure of interferencing protein, nucleic acid, protein-nucleic acid mixture, it is complete keeping primary structure simultaneously.In solution, under chaotropic condition, biomolecules, particularly the intramolecular interaction of protein, protein-nucleic acid mixture and nucleic acid is disturbed, this is because chaotropic compound has been interfered the stabilization intramolecular interaction in the biomolecules, for example hydrogen bond, Van der Waals force and hydrophobicity effect.Chaotropic compound has the large volume ion usually, and it is owing to interaction in their size meeting interference molecules and therefore reduce polarity of solvent.Intermolecular hydrogen bonding and intramolecular hydrogen bond have been disturbed thus.Therefore, although numerous protein precipitates, still keep the spirane structure of double stranded nucleic acid fragment.By chaotropic compound is added in cell lysate or the cell suspension, protein can be precipitated, and nucleic acid remains in the solution simultaneously.Under chaotropic condition, nucleic acid is supported with the combining significantly of matrix based on silicon-dioxide.Chaotropic compound comprises, for example, and high-molecular weight urea solution (for example 6 to 8mol/l ureas), guanidinesalt solution (Guanidinium-
) (for example, 6mol/l chlorination guanidine), high molecular lithium salts (for example 4.5mol/l lithium perchlorate).Chaotropic anion comprises following negatively charged ion: F
-, PO
4 3-, SO
4 2-, CH
3COO
-, Cl
-, Br particularly
-, I
-, NO
3 -, ClO
4 -, SCN
-And Cl
3CCOO
-Chaotropic positively charged ion comprises following positively charged ion: Li
+, Mg
2+, Ca
2+, Ba
2+, guanidine positively charged ion (Guanidiniumkation) particularly, [CH
6N
3]
+For the preferred chaotropic compound of separate nucleic acid is isocyanic acid guanidine ([CH
6N
3]
+SCN
-) and the chlorination guanidine.
Term " non-chaotropic condition " be meant the water-based that does not have chaotropic reagent and/solvent condition in the alcohol solution.
Non-nucleic acid component not exclusively or is fully removed in term " purification of nucleic acid " expression from the sample that contains nucleic acid.This term is not limited to realize certain purity level.
Term " automatization purifying " be included in steps in or only in part steps, replace personnel's manual method, be used in particular for specific damping fluid disturb the step of biological material body, the step that adds magnetic-particle or alternative engagement means, step, the step of removing unabsorbed sample constituents, washing step in the specified temp cultivation, at specified temp from the solid-phase matrix for example step and the step of separating eluate from particle suspension liquid of magnetic-particle elution of bound nucleic acid.
Term " separation " comprises that removing all as far as possible is not biological substance or the chemical substance or the composition of true separate targets, that is, be not nucleic acid basically.Particularly, isolating these materials can avoid interference during actual combination, enrichment, purifying and subsequent detection target molecule or interfere.
Term " cell debris " comprises all biotic components, and it is not the major objective of separate nucleic acid, and will be by purifying or negative step and the living target molecular separation selected.Behind the lysing cell sample, described cell sample comprises (particularly in the aqueous solution) insoluble or difficult cracked cellular constituent, for example cause downright bad structural constituent, bone or lime structure (Kalkstrukturen), Microcalcification particularly, and break or the red corpuscle of morphology change, sarcoma sample and papilloma sample weave construction and special bacterium, it has complicated, difficult cracked sugar-coat (as mycobacterium).In addition, this comprises the structure of protein, film component, particularly curing cross-linked.But in some cases, it can be water soluble component, and it can discharge also separated according to above-mentioned cracking process.Example is a large amount of discharges and with respect to the oxyphorase of nucleic acid molar excess behind cracking (for example by the hypotonic buffer condition) red corpuscle, be with its separation before continuing to handle sample body.In addition, especially, " cell debris " is illustrated in and is not the composition of nucleic acid in ight soil/movement.Ight soil not only comprises the indigestibility part of food (coarse food grain), also comprises indigested residuum, and its top at large intestine is not absorbed, for example fat, starch, connective fiber and meat fiber and water.The endogenous substance that exists comprises: contain the intestinal cells that comes off of wanting isolating nucleic acid, digestive ferment and mucous residuum.In addition, a spot of bile acide itself and also can discharge with a spot of Yelkin TTS and a spot of other phosphatide of protection intestinal mucosa and can discharge together by follower ight soil from gall-bladder.
Term " magnetic-particle " comprises organic magnetic-particle and inorganic magnetic particle.
Term " silicon oxide (Silika) " comprises silicon-dioxide and silica derivative, particularly SiO
2Crystal and other forms of SiO
2, for example by SiO
2Diatomite, zeolites, soft silica, glass powder, silicic acid, water glass and the pure aluminium silicate and the reactive silicate that constitute.
Term " hydrophobic base " is meant solid phase, and its surface is made by hydrophobic material, is particularly made by hydrophobic synthetic materials, and polyolefine for example is as polypropylene (PP), polyethylene (PE), halogenated polyolefin, as PTFE (tetrafluoroethylene) etc.This matrix can any suitable form exist, and for example exists with forms such as particle, fiber, planes.Especially, this matrix can container inner wall (
) form exist.
Term " lysis buffer system " comprises following buffering system, and it comprises at least a interferential material that can cause or promote cell, cell system, cellular constituent or other biological mixture or structure.Especially, this material usually is selected from washing composition (Detergenzien) (Triton X-100, SDS etc.) or enzyme reagent as Proteinase K particularly.Also comprise and use the reagent that is selected from the aqueous solution, buffered soln or non-cushioned solution (the simplest situation is water).In the lysis buffer system, can mix one or more that are selected from a class or multiclass, or be mixed with each other.In scope of the present invention, the reagent that comprises chaotropic material is not illustrated in the composition of the lysis buffer system in the purifying first step.
Other terms that use among the present invention have common, implication well known by persons skilled in the art.
Summary of the invention
The present invention relates to a kind of method of nucleic acid of purifying biological sample, comprise the following steps:
A) with the sample collection in first sample receiver in the aqueous solution, and non-under the condition of liquid sequence height (nicht-chaotropen) this sample of cracking;
B) first magnetic-particle is suspended in this solution;
C) first sample receiver is introduced in the sample receiver clamper, in the ring internal space of the ring-shaped magnet of wherein this sample receiver introducing is associated with this sample receiver clamper (assoziierten);
D) solution and magnetic-particle are separated; With
E) isolating nucleic acid from solution.
The invention still further relates to the sample receiver clamper that a kind of Department of Automation that implements this method unifies and implements this method.
The present invention is based on following understanding: cell debris can be removed from solution effectively by magnetic-particle.Produce multiple advantage by this application: sample receiver is stabilized in this clamper especially by collecting sample receiver in the ring internal space of magnet.Magnetic force acts on magnetic-particle equably, and forms the magnetic-particle of annular edge sample and the deposition of cell debris on the sample receiver wall.The protuberance of particulate ring-type formation of deposits is especially little, and fragment is deposited on the sample receiver wall with annular distribution, make and for example by using liquid-transfering device, minimized the risk that pollutes because of contact transfer pipet point simultaneously by extracting liq sample effectively.More particularly, avoided dispersing like that and formed magnetic-particle structure deposition with hedgehog sample or the full nail of nail, especially as at the action of a magnetic field in viewed in the bar-shaped magnet situation of a side.Therefore, this method is particularly suitable for automatic mode.
Especially, use ring-shaped magnet that following advantage also is provided:
Ring-shaped magnet has and is parallel to the field direction that encircles symmetry axis, and this has produced the most intensive particles settling, rather than as when bar magnet, observe form linear structure (so-called " hedgehog structure (Igelstrukturen) ") along field wire.
Ring-shaped magnet has minimized the location of mistake that sample receiver may exist in the automatization liquor-transferring system (the so-called liquid automatic gear of moving), and has therefore minimized the dislocation arrangement of automatization liquid shifting equipment.
Ring-shaped magnet has minimized the particle loss or has moved the risk of polluting in the liquid automatic gear.
The present invention is also based on following knowledge: have the sample receiver clamper of ring-shaped magnet can be in a material cell a plurality of functional steps of linking automation purifying: a) in the sample receiver clamper, identify sample by the barcode that reads on the sample receiver; B) add reagent, as lysis buffer and/or Proteinase K and magnetic-particle; C) cracking and add magnetic-particle after, remove fragment in the sample receiver by the magnetization of the ring-shaped magnet in the sample receiver clamper.At this, the feature of the inventive method is particularly in do not need automatic gear needle point pumping liquid in step a-c.Suction and relevant transfer liquid enter second sample receiver to carry out after only removing fragment or interference composition with magnetic-particle under non-chaotropic condition.
According to an aspect of the present invention, the mean sizes of this magnetic-particle＜50 μ m, preferred＜10 μ m, preferred＜0.5 μ m does not get rid of＜0.1 μ m especially, and wherein this size is determined by the transmission electron microscopy method.
According to an aspect of the present invention, these particles have siliceous coating, particularly comprise the coating of silicon-dioxide.These magnetic-particles for example from EP 1468430 as can be known.
This magnetic-particle preferably has silica coating,, is coated with SiO that is
2Magnetic-particle.Statement " SiO
2The magnetic-particle of-coating " comprise magnetic core, it is by the Fe of at least 90% weight
3O
4Constitute, and its surface-coated has silicate.
Magnetic-particle is suspensible particle, and it can be fixed in the magnetic field by applying the external magnetic field.
By after the immobilized particles of magnetic field, magnetic-particle is separated from solution; Separation solution and particle are in any suitable manner for example undertaken by decantation, absorption etc. then.
According to step (e) from the sample isolating nucleic acid can be any suitable method implement, for example extracting method, based on the method for post, the precipitator method etc.The isolating nucleic acid of step (e) is not subjected to the restriction of any certain pure of isolating nucleic acid.
In step (a), in the aqueous solution, collect sample.This can work by mixing, suspension, emulsification or stripping.This sample can be reduced in size mechanically before or after being collected in the aqueous solution, for example by mechanical effect (as cutting, stirring), and by heat effect, or by similar fashion such as supersound process.Yet, can also with complete tissue sample for example tissue slice directly be suspended in the aqueous solution.
According to an aspect of the present invention, this sample is a blood sample.Under whole blood cracked situation, oxyphorase and red corpuscle and white corpuscle film component in large quantities and relative nucleic acid molar excess be released, and can in step (d), separate.Then, step (e) is used for purpose ground from residue aqueous phase purification of nucleic acid.
Perhaps, as described in technical, can implement the selective splitting red corpuscle, under hypotonic buffer condition for example.This discharges oxyphorase and erythrocyte membrane in large quantities, and they can be separated in step (d).In this case, still the release of the white corpuscle cracking of demand and nucleic acid will be in step e) realizes when adding chaotropic damping fluid and possible protein enzyme K.This method has realized simply and full automatic particularly extracting nucleic acid the white corpuscle from blood, and can avoid loaded down with trivial details method steps, as centrifugal and move liquid white corpuscle and abandoning supernatant.
According to a further aspect in the invention, this sample is movement/ight soil sample.The cracking of ight soil with health or pathology on nucleic acid in the intestinal epithelial cells (Darmepithelzellen) that change, that discharge be released in cell rests thing, coarse food grain, not in the complex matrices of digest food residuum (as fat, starch, connective fiber and meat fiber, digestive ferment and mucous resistates, bile acide, Yelkin TTS and other phosphatide).
Can in step d), completely or partially do not separated for all the components of nucleic acid in the sample.Then, step e) is used in particular for the nucleic acid of purpose ground purifying residue aqueous phase.
According to an aspect of the present invention, biological material is the sample that is embedded into paraffin, particularly paraffin section, and/or the fixing paraffin section of sample, particularly formaldehyde fixed.
The inventive method is particularly suitable for the fixed processing sample, because fixedly sample comprises a large amount of fragments especially, this is because protein and nucleic acid crosslinked for example.
According to a preferred aspect of the present invention, (d) is heated at least 50 ℃ with solution before in step, and preferred 50-95 ℃, preferably at least 60 ℃, more preferably 60-80 ℃.An advantage of this heating is to have realized the better suspension in the aqueous solution and the improved cracking of cell sample.For more effectively cracking, preferably add proteolytic enzyme, particularly Proteinase K.
According to an aspect of the present invention, in step (d) before, sample is cooled to once more is lower than 50 ℃.Exist in sample in the situation of paraffin, be cooled to and be lower than 50 ℃ and have following extra advantage: paraffin solidifies once more, for example is rendered as the paraffin loop type on the wall of container.Sample or lysate can use transfer pipet point to be very easy to and accurately suction then, and do not produce any blockage problem, and paraffin is retained in the reaction vessel with the form of described paraffin ring.
According to a further aspect in the invention, sample or lysate are by for example being collected in the container that comprises hydrophobic synthetic materials and contact with hydrophobic base.This is particularly preferred when processing contains the paraffin sample.Be suitable for use as the hydrophobic base of this purpose, for example, be the Eppendorf or the Sarstedt reaction vessel of knowing that contain polyolefine (as polypropylene and polyethylene).Particularly preferably being the paraffin sample that contains that will contact with hydrophobic base before in step (d) is heated to above 50 ℃, because paraffin therefore can be and dissolving and advantageously when cooling on the fluid surface in matrix sedimentation be ring, the fluid surface of matrix is the container edge in the building-up reactions container situation for example.This phenomenon be because the absorption process of liquefied petrolatum on hydrophobic base.Therefore, liquid sample then can be in subsequent step advantageously, accurately be sucked, and do not stop up the transfer pipet point, paraffin environmental protection is simultaneously stayed in the reaction vessel.
According to a further aspect in the invention, the purification efficiency of described method is so high, to such an extent as to use for great majority, enough uses single 3～20 μ m paraffin sections, very particularly preferably single 10 μ m paraffin sections, thus realize the very nucleic acid of high yield.Therefore, the consumption of paraffin is lower than and prevents or critical amount that interference ring forms.
According to an aspect of the present invention, the solution in the step (d) separates with magnetic-particle by suction.
According to an aspect of the present invention, step (e) further comprises the chaotropic compound of adding in solution.This can be included in and add proteolytic enzyme (if Proteinase K has been used for step (a)) in the step (e) first or repeatedly, that is, and and before or after adding chaotropic solution.
According to an aspect of the present invention, step (e) also comprises the magnetic-particle that contains silicon coating that has that adds use (fresh) in solution.
For isolation of RNA, preferably the DNase with biologic effective dose adds in the sample.This causes DNA quilt " digestion " and enters in the solution, and indigested RNA can separate from solution simultaneously.The digestion of DNase can different time points during milking be implemented, as far back as after the cracking and the latest behind the wash-out of purifying terminal point.
For purify DNA, preferably the RNase with biologic effective dose is added in the sample, and RNA can be digested thus, and complete DNA can separate from sample.RNase digestion can different time points during milking be implemented, as far back as after the cracking and the latest behind the wash-out of purifying terminal point.Yet, preferably in the presence of copurification RNA, detect DNA, that is, use buffer condition by omitting the RNase step or passing through, this has realized selective separation DNA and has got rid of RNA.
According on the other hand, when in the ring internal space of sample receiver being introduced the ring-shaped magnet that is associated with the sample receiver clamper, each sample receiver at least once shifts out and moves into described each sample receiver from annular space by the motion on the annulate shaft direction.Therefore, sedimentary magnetic-particle deposits especially effectively and is distributed in the form of a ring on the sample receiver wall with fragment and the paraffin residues that may exist, and further minimizes sedimental any projection.Compare with the bar-shaped magnet (its action of a magnetic field is in a side) of routine, that ring-shaped magnet prevents especially is special, the formation of macroscopical visible needle-like or hedgehog magnetic-particle structure.
In the nucleic acid purification method of routine, sample material is collected or cracking in chaotropic damping fluid.The present invention is based on following beat all discovery, that is, when removing cell debris under non-chaotropic condition isolate nucleic acid from sample before, nucleic acid purification can bring improved result.This can realize by for example centrifugal or filtration.According to an embodiment of the invention, under non-chaotropic condition, remove fragment by magnetic-particle.Preferably, these particles have siliceous coating, particularly silica containing coating.These particles are known from EP 1468430, and the document is incorporated herein by reference.These particulate preparations will describe in further detail hereinafter.
Isolating nucleic acid can known method be implemented from the lysate of having removed fragment.For example, the suitable extraction experimental program that carries out purifying from chaotropic solution that is based on is for example by at chaotropic condition deposit nucleic acid and/or absorb to siliceous matrix.In known method based on post, nucleic acid is bonded to silicon oxide film from lysate in the presence of the high density chaotropic salt, and behind cleaning from film wash-out.Suitable device can be from Fa.QIAGEN GmbH, Hilden, and Bundesrepublik Deutschland buys.
According to a preferred aspect of the present invention, isolating nucleic acid is implemented by the magnetic-particle of using (fresh) silica-coated under chaotropic condition again.
According to a preferred aspect of the present invention, separate fragment or interfering substance and also can increase purification efficiency, reproducibility and steadiness, and the outlier in the minimizing foranalysis of nucleic acids and fuzzy or unclear result (result of " drift ", the result of " geflagte ").Except being used for research, these methods also are used for clinical diagnosis, and this is relevant with repeated test or reflection measurement, and relate to extra and inevitable cost.
According on the other hand, the present invention includes the automation system of implementing the inventive method, comprising:
-be used for the support (Ablage) of at least one sample receiver;
But-temperature control unit, it has at least one groove that is used for sample receiver (Aufnahme);
-sample receiver clamper is used to receive at least one sample receiver;
But-be used for the sample receiver clamper is transported to from support the equipment of temperature control unit;
-be used for liquid from the sample receiver jump routine as entering the device of another sample receiver or cleaning plant (waste material);
But-be used to the temperature controlling device controlling e Foerderanlage, liquid transfer device and be used to control temperature control unit;
The wherein said sample receiver clamper that is used to receive at least one sample receiver has at least one ring-shaped magnet, can receive sample receiver in the ring internal space of this ring-shaped magnet.
The invention still further relates to the sample receiver clamper that is used to hold at least one sample receiver, this clamper has at least one ring-shaped magnet, can hold described sample receiver in this ring internal space.
Preferably, the ring inside diameter at the narrow location place of described ring-shaped magnet is 4～50mm, 4～20mm, 5～15mm, preferred 6～12mm, more preferably 8mm.
Described ring internal space has conical area, and it preferably is complementary with the shape and the geometrical dimension of each sample receiver.
This sample receiver clamper can comprise a plurality of grooves that are used for sample receiver, for example 2～1600, and preferred 2～96, preferred 2,4,6,8 or 12.Mode that these grooves can be arranged or quadrature orthogonal mode are arranged, and particularly arrange in the mode of 2x2,2x3,4x6,6x8,8x12,16x24 or 32x48, as usually using in the in-vitro diagnosis.
Below, further specify the present invention by detailed embodiment and accompanying drawing, in the accompanying drawings:
Fig. 1 has shown the specimen holder with the bar-shaped magnet of fixed according to prior art
Synoptic diagram, this bar-shaped magnet has the magnetic field that acts on a side.
Fig. 2 has shown the vertical view of the specimen holder that is used for the inventive method.
Fig. 3 has shown the sectional view of the specimen holder that is used for the inventive method.
Figure 4 and 5 have shown the specimen holder (Fig. 4) in prior art and have been used for side of the present invention
The multi-form synoptic diagram of particle deposition in the specimen holder of method (Fig. 5).
Fig. 6 has shown the synoptic diagram of the progress of the inventive method.
Fig. 7 has shown the synoptic diagram of the inventive method.
Fig. 1 schematically illustrates the setting according to the sample receiver 10 and the magnet 20 of prior art.This setting for example is disclosed among the WO1990014891A1.
Fig. 2 and 3 has shown the setting of sample receiver used according to the invention 10 and ring-shaped magnet 22.Magnet 22 can be for for example by K﹠amp; J Magnetics Inc., Jamison, PA 18929, and the ring-shaped magnet that USA sells has multiple model.Preferably, use strong neodium magnet, for example comprise the magnet that contains neodymium alloy (as NdFeB).The ring-shaped magnet that is particularly suitable for widely used Eppendorf reaction vessel in the diagnostics (volume/be of a size of 1.5-2.5ml) is of a size of external diameter 1～2cm, 12mm for example, internal diameter 5～12mm, for example 8mm.1.5ml the Eppendorf reaction vessel has external diameter 11mm at circular cylinder shaped portion, and when using internal diameter as the ring-shaped magnet of 8mm, this reaction vessel can be contained in the ring internal space of magnet via the tapered section of reaction vessel, and can firm thus or maintenance.Common sample receiver has liner at opening, thereby makes that can select or measure magnet makes internal diameter less than the liner diameter, but greater than the diameter of the cylindrical region of sample receiver liner below.By this way, sample receiver can keep by ring-shaped magnet.
The ring internal space can also be conical for taper shape or part, with the conical area complementation of sample receiver, thereby can suitably hold this container.
Fig. 4 has shown that use has caused the violent projection of the deposition 30 of magnetic-particle according to the specimen holder of prior art, and uses specimen holder according to the present invention to cause that the annular than small embossment deposits (Fig. 5).Can find out further that the magnetic force here eliminates each other, and in the situation that Fig. 4 shows, sample receiver is to the direction of arrow skew of magnet 20, and this is disadvantageous especially in automatic mode, because suction transfer pipet (not shown) can increase with deposition 30 or with the risk of not expecting that contacts of sample receiver 10.In addition, use ring-shaped magnet as shown in Figure 5, avoided the formation of the magnetic-particle structure of dispersing especially with hedgehog sample or pin sample loading mode, and this especially with the similar bar-shaped magnet of Fig. 4 (having the magnetic field of arranging) along a direction in can observe.
As shown in Figure 6, when in the ring internal space of sample receiver being inserted the ring-shaped magnet that is associated with the sample receiver clamper, sample receiver 10 can shift out and move at least once once more from annulus by motion on the annulate shaft direction.Therefore, sedimentary magnetic-particle 30 is deposited especially effectively with the fragment and the paraffin residues that may exist, and being distributed on the sample receiver wall in the form of a ring, thereby further minimizes any possible deposition projection.This is particularly advantageous under the situation of described purifying paraffin section, because paraffin " was smeared " and was distributed on the wall of container this moment, and minimizes the risk of stopping up suction unit.
Fig. 7 schematically shows the inventive method.Described method can manually or in the automatization mode be carried out.
Embodiment:
Material and method:
In all following examples, use following material and method:
Parent material is from the breadboard tumour sample of clinical pathology, and it is fixed in the formaldehyde when collecting and then is embedded in the paraffin.These are fixed and embedding method is known to those skilled in the art, and do not go through at this.Use slicing machine, obtaining thickness from sample for example is the tissue slice of 5～10 μ m, and it is transferred in the 1.5ml sample receiver, for example 1.5ml polypropylene sample receiver (" Eppendorf container " as is known).Perhaps, also the sample that is applied to slide glass can be used scraper or other suitable manner (as, with ethanol/dimethylbenzene deparaffinization) peel off from above or scrape off, and be transferred in the sample receiver.
Except from Siemens Healthcare Diagnostics GmbH (Erlangen, Deutschland) " the Versant kPCR Sample Preparation Reagents " that buy is (by Proteinase K solution, binding buffer liquid (contains chaotropic agent, for example 59% guanidine thiocyanate and 10% octylphenoxy polyethoxy ethanol), the magnetic-particle of silica-coating (for example known) by EP 1468430, lavation buffer solution 1 (contains chaotropic agent, for example 36% guanidine thiocyanate and 30% ethanol, lavation buffer solution 2 (containing 80% ethanol), outside lavation buffer solution 3 (containing 5-chloro-2-methyl-4-isothiazoline-3-ketone and 2-methyl-4-isothiazoline-3-ketone (3: 1)) and the elution buffer (containing sodiumazide), use following damping fluid:
1.FFPE lysis buffer
10mM?Tris-HCl
0.1mM?EDTA
2％SDS
pH?8.0
2. do not contain DNA DNAse solution (Ambion, Cat#A 1906, Ambion, Foster City, CA 94404, USA)
Replacement can also be used other common buffer compositions well known by persons skilled in the art from " Versant kPCR Sample Preparation Reagents " that Siemens Healthcare Diagnostics GmbH buys.Containing washing composition and/or hypotonic damping fluid is particularly suitable FFPE lysis buffer.Suitable lavation buffer solution is known similarly from prior art, and can buy acquisition.The magnetic bead that can be used for follow-up use silicon oxide-coating is chaotropic buffer compositions from the binding buffer liquid of lysate isolating nucleic acid, 4.5M guanidine HCl for example, 6M isocyanic acid guanidine etc.Suitable lavation buffer solution must only meet the requirement of guaranteeing that nucleic acid is not peeled off from silicon oxide substrate.Generally speaking, high alcohol-content and optional weakly alkaline pH are enough for the self-dissolving that prevents DNA.The lavation buffer solution that contains chaotropic compound also is fit to, as long as they satisfy above-mentioned condition.Possible elution buffer also is a buffer compositions well known by persons skilled in the art, for example TE damping fluid (pH 8.0 for 10mM Tris-HCl, 0.1mMEDTA).
Should be understood that, in the experimental program of this purifying and similar purifying, RNA can be broken into the long fragment of 100 to 500 base pairs, but for the expression analysis (RT-PCR that uses existing method to carry out, microarraies etc.), the RNA of fragmentation also is very suitable.
(relatively) quantitatively RNA productive rate realizes by the TaqMan probe by a step dynamic real-time ThermoScript II polymerase chain reaction (one-step kRT-PCR).For analyzing the RNA productive rate, determine contrast or housekeeping gene RPL37A (that is mRNA of the people's gene of ribosomal protein L 37a,, GenBank accession number NM_000998) CT value (cycle threshold, that is, the value of amplification cycles, it at first surpasses the threshold value of determining).Use " SuperScriptTM one step usefulness
Taq kit " (Deutschland) (Eurogentec, Cologne Deutschland) implement qRT-PCR with using primer and probe for Invitrogen, Karlsruhe.In order to implement kRT-PCR expression analysis RPL37A, the purifying RNA of 1 μ l is added in the masterbatch of 9 μ l, it comprises 400nM forward primer, 400nM reverse primer, 200nM TaqMan probe (FAM/TAMRA-mark), and reaction mixture respectively contains 0.2mMdNTP and 1.2mM sal epsom and 1 μ l
Taq Mix.Be reflected at ABI7900 equipment (AppliedBiosystems, Applera Deutschland GmbH, Darmstadt, Deutschland) use following temperature curve to carry out:
-50 ℃, 30 minutes
-95 ℃, 2 minutes
-95 ℃, 15 seconds
-60 ℃, 30 seconds, 40 circulations
In order to establish the CT value, use software SDS 2.0 (Applied Biosystems) according to operation instructions.The CT value is higher than this number of times corresponding to the amplification cycles number of times, and then amplified signal surpasses preset threshold, for example measures threshold value.It is many more to be present in nucleic acid in the sample or RNA or DNA, and then corresponding C T value is low more.In some cases, the CT value of RPL37A is given the 40-CT in the accompanying drawing, the purpose that is used for better presenting.By this way, get the inverse of this value, higher 40-CT value is corresponding to the RPL37A of high expression level more.Unless detailed description is arranged in addition, otherwise the CT value that expression is directly measured.
Embodiment 1: remove the paraffin section isolation of RNA of fragment from formaldehyde fixed by adding magnetic-particle under non-chaotropic condition
This method is corresponding to the method for illustrating among Fig. 7.
Will be according to the manual purifying of following measure from the RNA of FFPE tissue slice:
-will be at the FFPE tissue slice in the Eppendorf sample receiver centrifugal 1 minute with maximum rate;
-adding 150 μ l FFPE lysis buffers and 50 μ l Proteinase Ks
-cultivate 2 hours (corresponding to the step 1) of Fig. 7 65 ℃ of vibrations;
-adding 50 μ l magnetic-particles;
-mix (corresponding to the step 2 among Fig. 7) by 2 minutes vibrations;
-sample receiver is introduced in the annular space of magnet, choose wantonly and further move up and down this sample receiver (corresponding to the step 3) among Fig. 7;
-for example carefully supernatant liquor is moved in the new container (cell debris and paraffin residues are retained in the original container) (corresponding to the step 4) among Fig. 7 by moving liquid.
Below can be from supernatant liquor isolating nucleic acid, for example undertaken by following steps:
-adding 800 μ l binding buffer liquid (chaotropic agent);
-adding 50 μ l magnetic-particles;
-cultivated 15 minutes in the room temperature vibration;
-applying magnetic field, suction is abandoning supernatant also;
-except that demagnetizing field.This magnetic-particle (with top bonded nucleic acid) is collected and is suspended in the 850 μ l lavation buffer solutions 1;
-applying magnetic field, suction is abandoning supernatant also;
-except that demagnetizing field.This magnetic-particle (with top bonded nucleic acid) is collected and is suspended in the 450 μ l lavation buffer solutions 2;
-applying magnetic field, suction is abandoning supernatant also;
-except that demagnetizing field.This magnetic-particle (with top bonded nucleic acid) is collected and is suspended in the 450 μ l lavation buffer solutions 3;
-usefulness lavation buffer solution 3 repetitive scrubbings;
-after applying magnetic field and removing supernatant liquor, sample collection in 100 μ l elution buffers, was cultivated 10 minutes 70 ℃ of vibrations in hot mixing tank;
-apply magnetic field, and elutriant is transferred in the fresh sample receiver;
-adding 10 μ l 10x DNAse damping fluids and 1 μ l DNAse I;
-cultivated 30 minutes at 37 ℃;
-freezing sample and/or further analyze elutriant.
In Fig. 7, schematically show the inventive method.It can be manually or automatic operating.
Embodiment 2: use and the extra bonded step of magnetic-particle are with the tissue slice automatization purifying RNA of isolated cell fragment from formaldehyde fixed under non-chaotropic condition
Use following automation experiment scheme at the Siemens platform, VERSANT kPCR (extraction unit) goes up the RNA of purifying from the paraffin section of formaldehyde fixed.Can be at maximum 48 tissue slicies of purifying in service once.
Sample is prepared
By centrifugal tissue slice (5～10 μ m) glomeration that makes of room temperature, and placing Siemens to divide on the Sample carrier of sub-platform VERSANT kPCR, all here hardware modules (having sample receiver clamper, heater/shaker, magnet of ring-shaped magnet etc.), sample receiver, damping fluid and transfer pipet point all are arranged on its design attitude.
Purifying procedure begins:
-loading has the automatic gear of one or more sample receivers, sample receiver is introduced have in the sample receiver clamper of ring-shaped magnet
-beginning purifying procedure;
-the sample receiver clamper is introduced in the automatic gear space;
-in the sample receiver clamper, identify sample receiver and tracking by reading the barcode that is fixed on the sample receiver
-in having the sample receiver clamper of ring-shaped magnet, 150 μ l lysis buffers are added in the sample in the sample receiver;
-adding 50 μ l Proteinase K-solution;
-sample receiver is transferred on the heating vibration device, and cultivated 2 hours 65 ℃ of vibrations;
-adding 50 μ l magnetic-particle suspension;
-cultivated 10 minutes 65 ℃ of vibrations;
-do not apply vibration to cultivate 5 minutes;
-sample receiver is shifted back the sample receiver clamper from heating oscillator, and sample receiver is introduced in the annular space of magnet, choose wantonly and further move up and down sample receiver (corresponding to Fig. 7 step 3);
-magnetization sample 3 minutes;
-supernatant liquor is transferred to the deep hole (DWP) of sample board;
-adding 600 μ l binding buffer liquid (chaotropic agent);
-adding 50 μ l magnetic-particle suspension in DWP;
The vibration of-room temperature was cultivated 10 minutes;
-DWP is transferred to magnet;
-room temperature was cultivated 5 minutes in magnetic field;
-suction and abandoning supernatant;
-DWP is transferred to heating oscillator from magnet;
-adding 850 μ l lavation buffer solutions 1;
-room temperature was vibrated for 10 seconds;
-DWP is transferred to magnet;
-room temperature magnetization 2 minutes;
-suction and abandoning supernatant;
-DWP is transferred to heating oscillator from magnet;
-adding 450 μ l lavation buffer solutions 2;
-room temperature was vibrated for 10 seconds;
-DWP is transferred to magnet;
-room temperature magnetization 2 minutes;
-suction and abandoning supernatant;
-DWP is transferred to heating oscillator from magnet;
-adding 850 μ l lavation buffer solutions 3;
-room temperature was vibrated for 10 seconds;
-DWP is transferred to magnet;
-room temperature magnetization 2 minutes;
-suction and abandoning supernatant;
-adding 100 μ l elution buffers;
-DWP is transferred to heating oscillator from magnet;
-cultivated 10 minutes 70 ℃ of vibrations;
-DWP is transferred to magnet;
-Li goes into 12 μ l DNase-Mix (10 μ l 10x DNase-damping fluids; 2 μ l DNase 1);
-DWP is transferred to heating oscillator (being cooled to 37 ℃) from magnet;
-cultivated 30 minutes 37 ℃ of dead-beats;
-DWP is transferred to magnet;
-sample of DNase-digestion is transferred in the 1.5ml sample receiver;
Purifying procedure finishes
-freeze-drying sample and/or further analyze the RNA productive rate.
Therefrom as can be seen, compare, obtained significantly higher productive rate by remove the purifying that cell debris carries out according to the present invention with the sample that cell debris is not removed.Productive rate compares by the quantitative PCR of housekeeping gene RPL37A, and the amount of transcribing is made as 40-CT (CT=cycle threshold, that is, the quantity of amplification cycles surpasses the measurement threshold value of system at this).This has caused improved productive rate, and difference is from 3 to the 5CT values of RPL37A.This is from 8 to 32 corresponding to improve multiple in whole RNA.Reach a conclusion thus, at first, uncracked tissue or cell debris have damaged effectively and quantitative purification of nucleic acid, particularly RNA, may disturb nucleic acid to be bonded to the magnetic-particle of silicon oxide-coating under chaotropic condition.It can also be seen that under the non-chaotropic condition cracking sample being carried out and centrifugally replace to remove the purification step that cell debris can carry out with the extra magnetic-particle that uses silicon oxide-coating under non-chaotropic condition.Therefore, this has brought sizable advantage of very easy realization automatization for this method, and this is because no longer need further centrifugation step.
It can also be seen that, also caused more repeatably result (lower) between the serial section in tissue sample to remove fragment from otherness between the different RNA preparation of identical paraffin mass preparation in the extra magnetic decontamination step under the non-chaotropic condition.
The VERSANT kPCR system of Siemens, comprise from Hamilton move the liquid automatic gear, realize that all suction and the allocation step of control are used for each one liquid step of moving.Move pressure transmitter contained in the liquid passage by each and make liquid moving curve figure.(=TADM, all aspirate and distribute monitoring) write down in the variation of these pressure ratio in time during respectively moving the liquid step.For respectively moving the liquid step, can be to the certain allowed band of variation definition of pressure ratio.In case the TADM curve exceeds limited range, just can notice directly that the liquid step of moving of sample is not suitably carried out, it is stopped up, lacked by tip, and foam in liquid, the liquid forms or other side effects form.Sample can be followed mark and be used for subsequent analysis, perhaps can also get rid of from subsequent analysis in a stable condition.In clinical diagnosis, this information will cause reflection measurement or repeated test in many cases, in same system or be another optional method.
As can be seen, remove cell debris and improved the efficient that can move fluidity (as, suction cracking liquid) and automatization purifying, this is owing to still less getting rid of sample because of the bad luck of TADM curve.This has reduced the quantity of reflection measurement (implement this test once more and obtain the result) in the clinical diagnosis significantly, thereby has reduced cost.
Embodiment 3: from the blood sample purification of nucleic acid
The inventive method also is particularly suitable for from the whole blood sample purification of nucleic acid, removes dehemoglobinize or red corpuscle fragment because it has improved from blood.According to this method, at first under non-chaotropic condition, remove red corpuscle, the red corpuscle fragment that to interfere subsequent method step and also have the oxyphorase that discharges from sample effectively.
According to first scheme, the lysis buffer of 400 μ l (as 10mmol Tris-HCl, 0.1mmolEDTA, 2%SDS, pH 8.0) is added in the blood sample (as the EDTA of 100 μ l, whole blood sample).Then, the magnetic-particle suspension of 50 μ l (as, magnetic-particle uncoated or silicon oxide-coating) is added in the sample, then room temperature was cultivated 10 minutes, and by applying the magnetic field separation particle.Then as mentioned above, can be under chaotropic condition from the sample of removing isolating nucleic acid.
According to alternative plan, blood sample is collected in hypotonic lysis buffer, and (as, 25mM Tris-HCl, pH 7.5,10mM KCl, 5mM MgCl
2) in, directly cultivate with splitting erythrocyte, then magnetic-particle suspension (as, the magnetic-particle of uncoated or silicon oxide-coatings) is added in the sample, then the room temperature cultivation is 10 minutes, and by applying magnetic field separation particle and red corpuscle fragment and oxyphorase.Then cracking white corpuscle under chaotropic condition promptly, discharges nucleic acid, and it is bonded on the magnetic-particle of silicon oxide-coating of fresh interpolation.Can choose wantonly before chaotropic reagent or add Proteinase K simultaneously.
Embodiment 4: the preparation of the magnetic-particle of silicon oxide-coating
The magnetic-particle of silicon oxide-coating can be by for example preparing with the silica-coated magnetite ore particles.The magnetite preferred hydrophilic of using, can buy the ferriferous oxide (Fe of acquisition
3O
4), preferably it is narrow diameter distribution, and has spherical morphology.Magnetite ore particles is that purchase is obtainable, and this series products is prepared with trade(brand)name BAYOXIDE E by for example Fa.Bayer AG.Adequate types can trade(brand)name BAYOXIDE E8706, E8707, E8709 and E8710 obtain.Similar products like is also sold with trade(brand)name " Magnetic Pigment 340 " or " 345 " by BASF.Although use all these described products to obtain a good result, preferred BAYOXIDE E 8707 or E 8706 types used.This magnetic coating (Pigment) has spherical morphology, and average particulate diameter is 0.2 μ m, narrow diameter distribution (about 0.1 to 0.7 μ m).Parent material as introducing silicates can use alkali silicate (sodium silicate or potash water glass) (Alkali-silikate (Natron-oder Kali-
)) and silica gel.Suitable water glass, it has very high pH value (13-14) usually, is provided by a plurality of companies, for example Merck or Cognis.The material that applies, for example Bayoxide E 8707, can stir be added to dilution, for example in the water glass solution of 1% concentration.After cultivating about 30 minutes, filtering material, and wash drying with water.According to the exemplary experiment scheme, the Bayoxide E 8707 of 50g is stirred (HK30 in the sodium silicate solution of 0.25% concentration that adds 1000ml; Cognis), then room temperature restir 30 minutes.Filtering particle, and washing with water 5 times is with washing with alcohol 1 time, then dry 5 hours of 80C.
Claims (18)
1. the method for the nucleic acid of a purifying biological sample comprises the following steps:
(a) with the sample collection in first sample receiver in the aqueous solution, and under non-chaotropic condition this sample of cracking;
(b) first magnetic-particle is suspended in this solution;
(c) first sample receiver is introduced in the sample receiver clamper, wherein this sample receiver is introduced in the ring internal space of the ring-shaped magnet that is associated with this sample receiver clamper;
(d) solution and magnetic-particle are separated; With
(e) isolating nucleic acid from solution.
2. contain silicon coating according to the process of claim 1 wherein that described magnetic-particle comprises.
3. according to each method in the aforementioned claim, wherein said sample is a blood sample.
4. according to the method for claim 1 or 2, wherein said biological material is sample and/or the fixed sample that is embedded in the paraffin.
5. according to each method in the aforementioned claim, wherein before solution is heated at least 50 ℃, preferably at least 60 ℃, more preferably 60～95 ℃ in step (d).
6. according to the method for claim 5, wherein before, after the described sample of heating, sample is cooled to is lower than 50 ℃ again in step (d).
7. according to each method in the aforementioned claim, wherein said sample contacted with hydrophobic base at least one step among step (a) and (b) and (c).
8. according to the method for claim 7, wherein said first sample receiver is formed by hydrophobic material, and plays hydrophobic base.
9. according to each method in the aforementioned claim, wherein separate with magnetic-particle by suction at solution described in the step (d).
10. according to each method in the aforementioned claim, wherein step (e) comprises chaotropic compound is added in the described sample.
11. according to the method for claim 10, wherein step (e) also comprise with do not consume, have second magnetic-particle that contains silicon coating and be suspended in the solution.
12. according to the method for claim 11, wherein step (e) also comprises:
I) sample is received in second sample receiver, and adds chaotropic compound;
Ii) second magnetic-particle is suspended in the solution, and nucleic acid is bonded to second magnetic-particle,
Iii) second sample receiver is introduced the sample receiver clamper, wherein described second sample receiver is introduced in the ring internal space of the ring-shaped magnet that is associated with the sample receiver clamper; With
Iv) solution and magnetic-particle are separated, and with nucleic acid from the magnetic-particle wash-out.
13. according to each method in the aforementioned claim, in the time of wherein in the ring internal space of described first and/or second sample receiver being introduced the described ring-shaped magnet that is associated with the sample receiver clamper, described each sample receiver at least once shifts out and moves into described each sample receiver from annular space by the motion on the annulate shaft direction.
14. implement automation system, comprising according to the method for claim 1:
-be used for the support of at least one sample receiver;
But-temperature control unit, it has at least one groove that is used for sample receiver;
-sample receiver clamper is used to receive at least one sample receiver;
But-be used for the sample receiver clamper is transported to from support the equipment of temperature control unit;
-be used for liquid is migrated out and/or is transferred to from sample receiver the device of sample receiver;
But-be used to the temperature controlling device controlling e Foerderanlage, liquid transfer device and be used to control temperature control unit;
The wherein said sample receiver clamper that is used to receive at least one sample receiver has at least one ring-shaped magnet, can receive sample receiver in the ring internal space of this ring-shaped magnet.
15. the sample receiver clamper is used to keep at least one sample receiver, this clamper has at least one ring-shaped magnet, can keep described sample receiver in this ring internal space.
16. according to the sample receiver clamper of claim 15, the ring inside diameter at the narrow location place of wherein said ring-shaped magnet is 4～20mm, preferred 6～12mm, more preferably 8mm.
17. according to the sample receiver clamper of claim 15, wherein said ring internal space has conical area.
18., have a plurality of grooves that are used for sample receiver according to the sample receiver clamper of claim 15.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510856995.6A CN105349404A (en) | 2008-12-12 | 2009-11-20 | Method for purification of nucleic acids, particularly from fixed tissue |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008061714A DE102008061714A1 (en) | 2008-12-12 | 2008-12-12 | Process for the purification of nucleic acids, in particular from fixed tissue |
| DE102008061714.8 | 2008-12-12 | ||
| PCT/EP2009/065534 WO2010066554A1 (en) | 2008-12-12 | 2009-11-20 | Method for purification of nucleic acids, particularly from fixed tissue |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510856995.6A Division CN105349404A (en) | 2008-12-12 | 2009-11-20 | Method for purification of nucleic acids, particularly from fixed tissue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102245770A true CN102245770A (en) | 2011-11-16 |
Family
ID=41683033
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510856995.6A Pending CN105349404A (en) | 2008-12-12 | 2009-11-20 | Method for purification of nucleic acids, particularly from fixed tissue |
| CN2009801497428A Pending CN102245770A (en) | 2008-12-12 | 2009-11-20 | Method for purification of nucleic acids, particularly from fixed tissue |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510856995.6A Pending CN105349404A (en) | 2008-12-12 | 2009-11-20 | Method for purification of nucleic acids, particularly from fixed tissue |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US8703931B2 (en) |
| EP (2) | EP2356232B1 (en) |
| CN (2) | CN105349404A (en) |
| CA (1) | CA2746489C (en) |
| DE (1) | DE102008061714A1 (en) |
| WO (1) | WO2010066554A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105874053A (en) * | 2013-11-12 | 2016-08-17 | 韩国帕克特生物科技有限公司 | Multi-well cuvette provided with integrated reaction and detection means |
| CN106754345A (en) * | 2016-12-02 | 2017-05-31 | 上海默里科基因科技有限公司 | Nucleic acid-extracting apparatus |
| CN110452818A (en) * | 2019-07-17 | 2019-11-15 | 英诺维尔智能科技（苏州）有限公司 | A kind of pumping magnet cell separation sorting unit |
| CN111263662A (en) * | 2017-09-25 | 2020-06-09 | 宏布雷彻康系统工程公司 | Device and method for immobilizing biomolecules using magnetic particles |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101213619A (en) * | 2005-06-23 | 2008-07-02 | 西门子医疗系统诊断股份有限公司 | Magnetic particles with a closed ultrathin silica layer, method for the production thereof and their use |
| EP2539449B9 (en) * | 2010-02-26 | 2018-09-05 | Qiagen GmbH | Process for parallel isolation and/or purification of rna and dna |
| JP2014533952A (en) * | 2011-11-17 | 2014-12-18 | リーアニクス・インコーポレイテッドＲｈｅｏｎｉｘ， Ｉｎｃ． | Microfluidic device, method and application |
| DE102012210155A1 (en) | 2012-06-15 | 2013-12-19 | Siemens Aktiengesellschaft | Extracting specific blood components from liquid whole blood, comprises e.g. mixing whole blood sample with buffer, lysis enzyme and nucleic acid-binding magnetic bead dispersion, releasing nucleic acids by lysis and isolating and purifying |
| CA2905425A1 (en) * | 2013-03-13 | 2014-10-02 | Abbott Molecular Inc. | Methods of isolating nucleic acid using a lysis buffer containing ethanol |
| JP6431522B2 (en) * | 2013-03-15 | 2018-11-28 | アボツト・モレキユラー・インコーポレイテツド | One-step method for purification of nucleic acids |
| DE202014102945U1 (en) | 2014-06-27 | 2014-07-14 | Analytik Jena Ag | Heating and magnetic module for a device for the purification of nucleic acids |
| KR20160018172A (en) | 2014-08-08 | 2016-02-17 | 삼성전자주식회사 | Apparatus for fixing door and refrigerator having the same |
| US9663780B2 (en) | 2014-10-15 | 2017-05-30 | Alpaqua Engineering, LLC | Solid-core ring-magnet |
| FR3034431B1 (en) * | 2015-04-01 | 2019-06-07 | Ad Nucleis | AUTOMATED DATA PROCESSING SYSTEM AND METHOD FOR NUCLEIC ACID EXTRACTION ROBOT AND GENE AMPLIFICATION THROUGH THE REAL TIME PCR PROCESS |
| KR101646610B1 (en) * | 2015-05-28 | 2016-08-09 | (주)바이오니아 | High active magnetic silica nano particles for separating biomaterial and method for preparing the same |
| EP3347485B1 (en) * | 2015-09-11 | 2021-11-03 | Bacteria Detection Ltd | Methods for isolating microbial cells from a blood sample |
| DE102017200332A1 (en) * | 2017-01-11 | 2018-07-12 | Robert Bosch Gmbh | Method for extracting DNS |
| US20220064695A1 (en) * | 2018-03-11 | 2022-03-03 | Bacteria Detection Ltd | Methods for isolating microbial cells from a blood sample |
| CA3099275A1 (en) * | 2018-05-09 | 2019-11-14 | Dermtech, Inc. | Novel gene classifiers and uses thereof in autoimmune diseases |
| US11242519B2 (en) * | 2018-08-23 | 2022-02-08 | Alpaqua Engineering, LLC | Discontinuous wall hollow core magnet |
| DE102018132710A1 (en) | 2018-12-18 | 2020-06-18 | Analytik Jena Ag | Filtering method suitable for isolating and / or quantifying at least one substance to be examined from a sample |
| EP4032854A4 (en) * | 2019-09-19 | 2023-10-25 | Sanyo Chemical Industries, Ltd. | Magnetic particle composition, use of magnetic particle composition for nucleic acid separation, kit for obtaining magnetic particle composition, magnetic particles, chaotropic salt, and separation and purification method |
| TWI733302B (en) | 2020-01-09 | 2021-07-11 | 創想生物科技有限公司 | A method of isolating nucleic acids and the system thereof |
| EP4213620A4 (en) * | 2020-09-18 | 2024-11-13 | Advanced Cell Diagnostics Inc | Methods and compositions for removal of rna |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8900725A (en) | 1989-03-23 | 1990-10-16 | Az Univ Amsterdam | METHOD AND COMBINATION OF AGENTS FOR INSULATING NUCLEIC ACID. |
| NO168811C (en) | 1989-05-31 | 1992-04-08 | Dynal As | Separation device for separating magnetizable particles |
| US5346994A (en) | 1992-01-28 | 1994-09-13 | Piotr Chomczynski | Shelf-stable product and process for isolating RNA, DNA and proteins |
| US5897783A (en) * | 1992-09-24 | 1999-04-27 | Amersham International Plc | Magnetic separation method |
| GB9422814D0 (en) * | 1994-11-11 | 1995-01-04 | Medinnova Sf | Chemical method |
| CA2183638C (en) * | 1995-03-20 | 2001-03-20 | Tajima Hideji | Liquid processing method making use of pipette device and apparatus for same |
| US7078224B1 (en) | 1999-05-14 | 2006-07-18 | Promega Corporation | Cell concentration and lysate clearance using paramagnetic particles |
| US6194562B1 (en) * | 1998-04-22 | 2001-02-27 | Promega Corporation | Endotoxin reduction in nucleic acid purification |
| US6248535B1 (en) | 1999-12-20 | 2001-06-19 | University Of Southern California | Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
| DE10153957A1 (en) | 2001-11-06 | 2003-05-22 | Quiagen Gmbh | Process for the isolation of nucleic acids |
| DE10201084A1 (en) * | 2002-01-14 | 2003-07-24 | Bayer Ag | Magnetic particles containing silicon, process for their production and use of the particles |
| US7429356B2 (en) * | 2003-08-19 | 2008-09-30 | Fujifilm Corporation | Extracting apparatus |
| EP1510577A1 (en) * | 2003-08-29 | 2005-03-02 | Qiagen GmbH | Method for magnetic bead isolation of nucleic acids |
| WO2006071770A2 (en) * | 2004-12-23 | 2006-07-06 | I-Stat Corporation | Molecular diagnostics system and methods |
| DE102008029356A1 (en) * | 2008-06-20 | 2009-12-24 | Siemens Healthcare Diagnostics Gmbh | Process for the purification of nucleic acids, in particular from fixed tissue |
-
2008
- 2008-12-12 DE DE102008061714A patent/DE102008061714A1/en not_active Withdrawn
-
2009
- 2009-11-20 WO PCT/EP2009/065534 patent/WO2010066554A1/en active Application Filing
- 2009-11-20 EP EP09795728.6A patent/EP2356232B1/en active Active
- 2009-11-20 CA CA2746489A patent/CA2746489C/en active Active
- 2009-11-20 EP EP15186025.1A patent/EP2998398B1/en active Active
- 2009-11-20 CN CN201510856995.6A patent/CN105349404A/en active Pending
- 2009-11-20 US US13/133,182 patent/US8703931B2/en active Active
- 2009-11-20 CN CN2009801497428A patent/CN102245770A/en active Pending
-
2014
- 2014-03-06 US US14/199,019 patent/US9416399B2/en active Active
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105874053A (en) * | 2013-11-12 | 2016-08-17 | 韩国帕克特生物科技有限公司 | Multi-well cuvette provided with integrated reaction and detection means |
| CN106754345A (en) * | 2016-12-02 | 2017-05-31 | 上海默里科基因科技有限公司 | Nucleic acid-extracting apparatus |
| CN111263662A (en) * | 2017-09-25 | 2020-06-09 | 宏布雷彻康系统工程公司 | Device and method for immobilizing biomolecules using magnetic particles |
| CN110452818A (en) * | 2019-07-17 | 2019-11-15 | 英诺维尔智能科技（苏州）有限公司 | A kind of pumping magnet cell separation sorting unit |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2746489C (en) | 2018-05-01 |
| EP2998398A1 (en) | 2016-03-23 |
| CA2746489A1 (en) | 2010-06-17 |
| US20140186236A1 (en) | 2014-07-03 |
| CN105349404A (en) | 2016-02-24 |
| US9416399B2 (en) | 2016-08-16 |
| US8703931B2 (en) | 2014-04-22 |
| WO2010066554A1 (en) | 2010-06-17 |
| EP2998398B1 (en) | 2018-01-03 |
| DE102008061714A1 (en) | 2010-06-17 |
| US20110245483A1 (en) | 2011-10-06 |
| EP2356232A1 (en) | 2011-08-17 |
| EP2356232B1 (en) | 2016-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102245770A (en) | Method for purification of nucleic acids, particularly from fixed tissue | |
| US11060082B2 (en) | Polynucleotide capture materials, and systems using same | |
| DK2254698T3 (en) | MOBILE UNIT FOR nucleic acid isolation | |
| US20100009351A1 (en) | Polynucleotide Capture Materials, and Method of Using Same | |
| US8846897B2 (en) | Method for filtering nucleic acids, in particular from fixed tissue | |
| WO2010005444A1 (en) | Polynucleotide capture materials, and methods of using same | |
| AU2020202825B2 (en) | Polynucleotide capture materials, and methods of using same | |
| AU2023282224A1 (en) | Polynucleotide capture materials, and methods of using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20111116 |